CXCL13 Is a Biomarker of Anti-Leucine-Rich Glioma-Inactivated Protein 1 Encephalitis Patients [Response to Letter]
Sheng-jun Wang, Xue-wu Liu Department of Neurology, Qilu Hospital, Shandong University, Ji’nan, People’s Republic of ChinaCorrespondence: Sheng-jun Wang; Xue-wu LiuDepartment of Neurology, Qilu Hospital, Shandong University, 107# Wen Hua Xi Road, Ji’nan 250012, People&a...
Guardado en:
| Autores principales: | , |
|---|---|
| Formato: | article |
| Lenguaje: | EN |
| Publicado: |
Dove Medical Press
2020
|
| Materias: | |
| Acceso en línea: | https://doaj.org/article/aec84005bdda4c29aa41946044fb56fb |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
| id |
oai:doaj.org-article:aec84005bdda4c29aa41946044fb56fb |
|---|---|
| record_format |
dspace |
| spelling |
oai:doaj.org-article:aec84005bdda4c29aa41946044fb56fb2021-12-02T06:31:50ZCXCL13 Is a Biomarker of Anti-Leucine-Rich Glioma-Inactivated Protein 1 Encephalitis Patients [Response to Letter]1178-2021https://doaj.org/article/aec84005bdda4c29aa41946044fb56fb2020-01-01T00:00:00Zhttps://www.dovepress.com/response-cxcl13-is-a-biomarker-of-anti-leucine-rich-glioma-inactivated-peer-reviewed-article-NDThttps://doaj.org/toc/1178-2021Sheng-jun Wang, Xue-wu Liu Department of Neurology, Qilu Hospital, Shandong University, Ji’nan, People’s Republic of ChinaCorrespondence: Sheng-jun Wang; Xue-wu LiuDepartment of Neurology, Qilu Hospital, Shandong University, 107# Wen Hua Xi Road, Ji’nan 250012, People’s Republic of ChinaEmail junwang9999@sina.com; qiluliuym66@163.comThanks for the concerns and comments of Mr. Zuowei Duan. There were indeed some limitations in our published article since it was only a preliminary exploratory research. As for the rarity of LGI1 encephalitis, only sixteen patients were enrolled in our study. The multifactorial analysis of variance was hard to be evaluated. But we do believe the statistical significance of our finding about the increasing of CXCL13 levels in the patients.We agree that the clinical significance of CXCL13 levels increasing should not be over-estimated by clinicians. We have stated that the increasing of CXCL13 levels were reported in other autoimmune diseases including multiple sclerosis, neuroborreliosis and anti-NMDAR encephalitis in “Discussion Section” of our published article. The specificity and sensitivity of CXCL13 in serum/CSF for autoimmune encephalitis still need to be further investigated. Anyhow, we have found a potential biomarker for the diagnosis of anti-LGI1 encephalitis.This is in response to the Letter to the Editor View the original paper by Lin and colleagues. Wang SLiu XDove Medical PressarticleNeurosciences. Biological psychiatry. NeuropsychiatryRC321-571Neurology. Diseases of the nervous systemRC346-429ENNeuropsychiatric Disease and Treatment, Vol Volume 16, Pp 339-340 (2020) |
| institution |
DOAJ |
| collection |
DOAJ |
| language |
EN |
| topic |
Neurosciences. Biological psychiatry. Neuropsychiatry RC321-571 Neurology. Diseases of the nervous system RC346-429 |
| spellingShingle |
Neurosciences. Biological psychiatry. Neuropsychiatry RC321-571 Neurology. Diseases of the nervous system RC346-429 Wang S Liu X CXCL13 Is a Biomarker of Anti-Leucine-Rich Glioma-Inactivated Protein 1 Encephalitis Patients [Response to Letter] |
| description |
Sheng-jun Wang, Xue-wu Liu Department of Neurology, Qilu Hospital, Shandong University, Ji’nan, People’s Republic of ChinaCorrespondence: Sheng-jun Wang; Xue-wu LiuDepartment of Neurology, Qilu Hospital, Shandong University, 107# Wen Hua Xi Road, Ji’nan 250012, People’s Republic of ChinaEmail junwang9999@sina.com; qiluliuym66@163.comThanks for the concerns and comments of Mr. Zuowei Duan. There were indeed some limitations in our published article since it was only a preliminary exploratory research. As for the rarity of LGI1 encephalitis, only sixteen patients were enrolled in our study. The multifactorial analysis of variance was hard to be evaluated. But we do believe the statistical significance of our finding about the increasing of CXCL13 levels in the patients.We agree that the clinical significance of CXCL13 levels increasing should not be over-estimated by clinicians. We have stated that the increasing of CXCL13 levels were reported in other autoimmune diseases including multiple sclerosis, neuroborreliosis and anti-NMDAR encephalitis in “Discussion Section” of our published article. The specificity and sensitivity of CXCL13 in serum/CSF for autoimmune encephalitis still need to be further investigated. Anyhow, we have found a potential biomarker for the diagnosis of anti-LGI1 encephalitis.This is in response to the Letter to the Editor
View the original paper by Lin and colleagues.
|
| format |
article |
| author |
Wang S Liu X |
| author_facet |
Wang S Liu X |
| author_sort |
Wang S |
| title |
CXCL13 Is a Biomarker of Anti-Leucine-Rich Glioma-Inactivated Protein 1 Encephalitis Patients [Response to Letter] |
| title_short |
CXCL13 Is a Biomarker of Anti-Leucine-Rich Glioma-Inactivated Protein 1 Encephalitis Patients [Response to Letter] |
| title_full |
CXCL13 Is a Biomarker of Anti-Leucine-Rich Glioma-Inactivated Protein 1 Encephalitis Patients [Response to Letter] |
| title_fullStr |
CXCL13 Is a Biomarker of Anti-Leucine-Rich Glioma-Inactivated Protein 1 Encephalitis Patients [Response to Letter] |
| title_full_unstemmed |
CXCL13 Is a Biomarker of Anti-Leucine-Rich Glioma-Inactivated Protein 1 Encephalitis Patients [Response to Letter] |
| title_sort |
cxcl13 is a biomarker of anti-leucine-rich glioma-inactivated protein 1 encephalitis patients [response to letter] |
| publisher |
Dove Medical Press |
| publishDate |
2020 |
| url |
https://doaj.org/article/aec84005bdda4c29aa41946044fb56fb |
| work_keys_str_mv |
AT wangs cxcl13isabiomarkerofantileucinerichgliomainactivatedprotein1encephalitispatientsresponsetoletter AT liux cxcl13isabiomarkerofantileucinerichgliomainactivatedprotein1encephalitispatientsresponsetoletter |
| _version_ |
1718399894962569216 |